Astute Medical Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Astute Medical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7313
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Astute Medical Inc (Astute Medical), a subsidiary of BioMerieux SA is a diagnostic equipment provider. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through clinically useful tools for assessing acute conditions in critically ill patients. Astute Medical’s astute meter provides bench top and table top analyzer that converts the fluorescent signal from two immunoassays and provides test cartridge into a single numerical result. The company identifies and validates biomarkers of acute kidney injury. It has presence in the US and France. Astute Medical is headquartered in San Diego, California, the US.

Astute Medical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Astute Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Astute Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Astute Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Astute Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Astute Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Astute Medical Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Astute Medical Raises Additional USD1 Million in Venture Financing 10
Astute Medical Raises USD2 Million in Venture Financing 11
Astute Medical Raises USD20 Million in Venture Financing 12
Astute Medical Secures USD40 Million in Venture Funding from CRG (Capital Royalty) 13
Astute Medical Raises USD20 Million in Venture Financing 14
Astute Medical Raises US$40.4 Million In Series C Financing 15
Astute Medical Raises US$2 Million In Venture Financing 17
Partnerships 18
BioMerieux Enters into Licensing Agreement with Astute Medical 18
Astute Medical Enters into Distribution Agreement with bioMerieux 19
Astute Medical Enters into Distribution Agreement with Fosun Long March 20
Astute Medical Expands its Co-Marketing Agreement with Ortho-Clinical Diagnostics 21
Equity Offering 22
Astute Medical Raises USD43 Million in Private Palcement of Shares 22
Acquisition 23
bioMerieux Acquires Astute Medical for USD90 Million 23
Astute Medical Inc – Key Competitors 24
Astute Medical Inc – Key Employees 25
Astute Medical Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Astute Medical Inc, Medical Equipment, Key Facts 2
Astute Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Astute Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Astute Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Astute Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Astute Medical Inc, Deals By Market, 2012 to YTD 2018 8
Astute Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Astute Medical Raises Additional USD1 Million in Venture Financing 10
Astute Medical Raises USD2 Million in Venture Financing 11
Astute Medical Raises USD20 Million in Venture Financing 12
Astute Medical Secures USD40 Million in Venture Funding from CRG (Capital Royalty) 13
Astute Medical Raises USD20 Million in Venture Financing 14
Astute Medical Raises US$40.4 Million In Series C Financing 15
Astute Medical Raises US$2 Million In Venture Financing 17
BioMerieux Enters into Licensing Agreement with Astute Medical 18
Astute Medical Enters into Distribution Agreement with bioMerieux 19
Astute Medical Enters into Distribution Agreement with Fosun Long March 20
Astute Medical Expands its Co-Marketing Agreement with Ortho-Clinical Diagnostics 21
Astute Medical Raises USD43 Million in Private Palcement of Shares 22
bioMerieux Acquires Astute Medical for USD90 Million 23
Astute Medical Inc, Key Competitors 24
Astute Medical Inc, Key Employees 25
Astute Medical Inc, Subsidiaries 26

List of Figures
Astute Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Astute Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Astute Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Astute Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Astute Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Astute Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Astute Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Astute Medical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Astute Medical Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Total Petrochemicals & Refining USA Inc:企業の戦略的SWOT分析
    Total Petrochemicals & Refining USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • PT PLN (Persero):企業の発電所・SWOT分析2018
    PT PLN (Persero) - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Nissin Electric Co Ltd (6641):企業の財務・戦略的SWOT分析
    Nissin Electric Co Ltd (6641) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Network Rail Ltd:企業の戦略的SWOT分析
    Network Rail Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Volkswagen AG:戦略・SWOT・企業財務分析
    Volkswagen AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Mitek Systems Inc (MITK):企業の財務・戦略的SWOT分析
    Summary Mitek Systems Inc (Mitek) is a technology company that develops and markets payment and fraud prevention software products. The company offers products such as Mobile Verify, Mobile Docs, Mobile Fill, Mobile Deposit and Multi Check Capture. Its Mobile Verify is a Mitek's ID verification solu …
  • Hewlett Packard Enterprise Company:企業の戦略・SWOT・財務分析
    Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report Summary Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Dova Pharmaceuticals Inc (DOVA)-製薬・医療分野:企業M&A・提携分析
    Summary Dova Pharmaceuticals Inc (Dova) is a clinical-stage pharmaceutical company that develops therapies for the treatment of orphan diseases. The company’s lead candidate, Avatrombopag (AVA), a novel, oral thrombopoietin receptor agonist, is under development for the treatment of thrombocytopenia …
  • Topy Industries Ltd:企業の戦略・SWOT・財務情報
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Star Group LP (SGU):企業の財務・戦略的SWOT分析
    Summary Star Group LP (Star Group) formerly Star Gas Partners LP, is a distributor of home heating products and services. The company distributes and sells heating and air conditioning equipment, diesel fuel, gasoline, propane, and home heating oil. Star Group offers home security and plumbing, inst …
  • Thai Oil Public Co Ltd (TOP):企業の財務・戦略的SWOT分析
    Thai Oil Public Co Ltd (TOP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • NiSource Inc (NI):石油・ガス:M&Aディール及び事業提携情報
    Summary NiSource Inc (NiSource) is a regulated energy utility. The company distributes natural gas; and generates, transmits and distributes electricity. It produces electricity from coal, gas and hydro sources. NiSource operates electricity transmission systems and natural gas transmission pipeline …
  • Mmi Holdings Ltd.
    Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Alstom SA (ALO)-エネルギー分野:企業M&A・提携分析
    Summary Alstom SA (Alstom) is a manufacturer of transportation vehicles. It designs, develops and manufactures rail transport equipment, systems, services and signaling for urban, suburban, regional and main line passenger transportation, and for freight transportation. The company offers a wide ran …
  • vTv Therapeutics Inc (VTVT)-製薬・医療分野:企業M&A・提携分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc is a clinical stage pharmaceutical company that discovers, develops and commercializes small molecule drug candidates. The company’s pipeline products include azeliragon, TTP399, TTP273, HPP593, HPP737, HPP971 and hexokinase II inhibitors. I …
  • Simon Property Group, Inc.:企業の戦略・SWOT・財務情報
    Simon Property Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Simon Property Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Zain Group:企業の戦略・SWOT・財務分析
    Zain Group - Strategy, SWOT and Corporate Finance Report Summary Zain Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Fiesta Mart LLC:企業の戦略的SWOT分析
    Fiesta Mart LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • HepQuant Llc:製品パイプライン分析
    Summary Hepquant LLC (Hepquant) is a medical device company that provides diagnostic products. The company develops and markets products for measuring liver function. It offers products such as hepquant-stat, hepquant-shunt, and hepquant-flow. Hepquant’s hepquant-STAT is used in screening assay to i …
  • Thales SA:企業のM&A・事業提携・投資動向
    Thales SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Thales SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆